E-mail lunthesis@163.com Phone 0551-65179860-203

Domestic COVID drugs added to reimbursement list

Pub Date:2023-02-08 16:54 Source:China Daily

The National Healthcare Security Administration said on Wednesday that all domestic COVID-19 medicines have been added to the national medical reimbursement list.

Two newly approved homegrown pills — Xiannuoxin made by Simcere Pharmaceutical Group, and VV116 developed by Shanghai Vinnerna Biosciences — are temporarily covered up until March 31.

Azvudine, the first domestic COVID-19 oral medication developed by Henan Genuine Biotech, was officially included in the last version of the national reimbursement list that was released on Jan 18.

Three traditional Chinese medicine drugs and three herbal formulas have also been added to the list, the administration said.

Editor:徐静怡

Related News
- 'World's youngest' Alzheimer's patient diagnosed    2023-02-08 10:00
- Experts discuss WHO's recent COVID-related statement    2023-02-08 09:37
- Advance approval a must for COVID experiments    2023-02-03 16:35
- Certain COVID-19 experiments in Beijing prohibited    2023-02-03 15:12
 
photo  >>
Wuhu, Anhui: 100,000 mu of canola flowers blossoming
Guest countries of honor attract visitors at 6th CIIE
Video  >>
【网络中国节·元宵】 Happy Lantern Festival! Intangible cultural heritage in Anhui—— Fish Lantern 一夜“鱼”龙舞
2024 Chinese New Year: OMG! The God of Wealth is at your door!
People  >>
Hebei rolls out red carpet for talent
Transnational couple revives ancient dwelling in east China
Travel  >>
Huangshan listed among China's Top 10 scenic cities
China expects travel spree during May Day holiday
Contact Us
Copyright ©2000-2021 anhuinews.com All rights reserved. Reproduction in whole or in part without permission is prohibited. 皖B2-20080023-7